Search clinical trials for: Faslodex
Total 301 results
-
F2G Biotech GmbHQuotient ClinicalWithdrawnInvasive Aspergillosis
-
University of Wisconsin, MadisonAstraZeneca; University of PittsburghWithdrawnCarcinoma, Non Small Cell Lung
-
F2G Biotech GmbHQuotient ClinicalWithdrawn
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownRecurrent Uterine Corpus Carcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC v7
-
National Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Breast CarcinomaUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingAge-Related Macular Degeneration | Diabetic Macular Edema | Retinal Vein OcclusionChina
-
AstraZenecaActive, not recruitingHormone Receptor Positive Breast CancerCanada, Spain, United States, Romania, Taiwan, Italy, Brazil, Peru, Russian Federation, China, Czechia, Ukraine, South Africa, Japan, Poland, Mexico, United Kingdom, Argentina, Slovakia, Turkey
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Postmenopausal | Estrogen Receptor StatusUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor PositiveUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Royal Marsden NHS Foundation TrustPfizer; Breast Cancer NowActive, not recruitingGastric Cancer | Triple Negative Breast Cancer | Lobular Breast Carcinoma | CDH1 Gene MutationUnited Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
Baylor Breast Care CenterTerminatedBREAST CANCERUnited States
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownMetastatic Breast CancerItaly
-
Regina Elena Cancer InstituteAstraZenecaUnknown
-
National Cancer Institute (NCI)WithdrawnEstrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7
-
Frederic AmantKom Op Tegen Kanker; Research Foundation FlandersCompletedEndometrial Cancer | Endometrial Stromal Sarcoma | Sex Cord Stromal Tumor | Adenosarcoma of Uterus | Leiomyosarcoma Uterus | Serous Ovarian TumorBelgium, Netherlands
-
Beth Israel Deaconess Medical CenterUniversity of Colorado, Denver; Massachusetts General Hospital; Dana-Farber Cancer... and other collaboratorsActive, not recruiting
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Estrogen Receptor And/or Progesterone Receptor PositiveUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast CarcinomaUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedOvarian CancerUnited States
-
Hellenic Oncology Research GroupCompleted
-
AstraZenecaDendrix - Scientific Information ArchitectureCompleted
-
AstraZenecaActive, not recruitingAdvanced Metastatic Breast CancerUnited States
-
Atossa Therapeutics, Inc.TerminatedFemale Breast Carcinoma | Female Ductal Carcinoma In SituUnited States
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerBelgium, Turkey, Canada, Poland, Romania, Hungary, France, Czechia
-
AstraZenecaActive, not recruitingBreast CancerBelgium, Spain, Italy, United States, Brazil, Czechia, Russian Federation, Chile, Slovakia, Hungary, India, Ukraine, Colombia, Poland, Malta, Mexico, Venezuela
-
AstraZenecaCompletedPuberty, Precocious | McCune-Albright SyndromeItaly, United States, Germany, France, Russian Federation, United Kingdom
-
University of PennsylvaniaCompletedPulmonary Arterial HypertensionUnited States
-
Sun Yat-sen UniversityAstraZenecaUnknown
-
Fresenius KabiCompleted
-
Isabel BlancasCompletedMalignant Neoplasm of Breast Stage IVSpain
-
University of Colorado, DenverUnited States Department of DefenseActive, not recruitingBreast CancerUnited States
-
Kashiv BioSciences, LLCCompletedMetastatic Breast CancerJordan
-
Nuvation Bio Inc.WithdrawnBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Cancer of Breast | Malignant Tumor of Breast | Breast Tumor | Cancer of the BreastUnited States
-
Stanford UniversityAstraZenecaCompletedProstatic Neoplasms | Prostate CancerUnited States
-
AstraZenecaCompleted
-
The Center for Rheumatic Disease, Allergy, & ImmunologyAstraZenecaCompletedSystemic Lupus ErythematosusUnited States
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, United Kingdom, Germany, Austria, India
-
Celcuity IncNot yet recruiting
-
Phoenix Molecular DesignsRecruitingMetastatic Breast CancerUnited States
-
Carrick Therapeutics LimitedPfizerActive, not recruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerSpain, Turkey, United States, Mexico, Hungary
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
Novartis PharmaceuticalsActive, not recruiting
-
Massachusetts General HospitalExelixisActive, not recruitingBreast CancerUnited States
-
M.D. Anderson Cancer CenterEli Lilly and Company; AstraZenecaActive, not recruitingMalignant Neoplasms of Female Genital OrgansUnited States
-
Massachusetts General HospitalPuma Biotechnology, Inc.; Celcuity, Inc.WithdrawnMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast Cancer | Stage IV (Metastatic) Breast CancerUnited States
-
Novartis PharmaceuticalsNot yet recruitingAdvanced HR+/HER2- Breast Cancer | Advanced CCNE1-amplified Solid Tumors
-
German Breast GroupAstraZenecaNot yet recruitingCCCA Assessed by Ki67 Drop Below <2.7% From BaselineGermany
-
Biotheryx, Inc.Recruiting